Behavioral and biochemical characterization of rats treated chronically with thioacetamide: Proposal of an animal model for hepatic encephalopathy associated with cirrhosis

Journal of Toxicological Sciences

Volumn 37, Issue 6, 2012, Pages 1165-1175

  Kawai, Hiroshi ^a   Ishibashi, Takuya ^a   Kudo, Naomi ^b   Kawashima, Yoichi ^b   Mitsumoto, Atsushi ^a  

^a JOSAI INTERNATIONAL UNIVERSITY   (Japan)

^b JOSAI UNIVERSITY   (Japan)

Author keywords

5HT; Ammonia; Cirrhosis; Hepatic encephalopathy; Psychiatric deficit; Thioacetamide

Indexed keywords

4 AMINOBUTYRIC ACID; AMMONIA; GLUTAMINE; LACTULOSE; THIOACETAMIDE;

AMMONIA BLOOD LEVEL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CHEMICAL ANALYSIS; COGNITION; CONTROLLED STUDY; FORCED SWIMMING TEST; HEPATIC ENCEPHALOPATHY; IMMOBILIZATION; LIVER CIRRHOSIS; MALE; MEMORY DISORDER; MOOD; NONHUMAN; RAT;

EID: 84870910252     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.37.1165     Document Type: Article

References (42)

1. Bassett, M.L., Mullen, K.D., Skolnick, P. and Jones, E.A. (1987): Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure. Gastroenterology, 93, 1069-1077.
2. Bergeron, M., Reader, T.A., Layrargues, G.P. and Butterworth, R.F. (1989): Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Neurochem. Res., 14, 853-859.
3. Bernardini, P. and Fischer, J.E. (1982): Amino acid imbalance and hepatic encephalopathy. Annu. Rev. Nutr., 2, 419-454.
4. Butterworth, R.F., Norenberg, M.D., Felipo, V., Ferenci, P., Albrecht, J., Blei, A.T. and Members of the ISHEN Commission on Experimental Models of HE (2009): Experimental models of hepatic encephalopathy: ISHEN guidelines. Liver Int., 29, 783-788.
5. Cascino, A., Cangiano, C., Fiaccadori, F., Ghinelli, F., Merli, M., Pelosi, G., Riggio, O., Rossi Fanelli, F., Sacchini, D., Stortoni, M. and Capocaccia, L. (1982): Plasma and cerebrospinal fluid amino acid patterns in hepatic encephalopathy. Dig. Dis. Sci., 27, 828-832.
6. Cryan, J.F., Markou, A. and Lucki, I. (2002): Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol. Sci., 23, 238-245.
7. Dashti, H., Jeppsson, B., Hagerstrand, I., Hultberg, B., Srinivas, U., Abdulla, M. and Bengmark, S. (1989): Thioacetamide and carbon tetrachloride-induced liver cirrhosis. Eur. Surg. Res., 21, 83-91.
8. Dere, E., Huston, J.P. and De Souza Silva, M.A. (2007): The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents. Neurosci. Biobehav. Rev., 31, 673-704.
9. Detke, M.J., Rickels, M. and Lucki, I. (1995): Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl), 121, 66-72.
10. Dornelles, A., de Lima, M.N.M., Grazziotin, M., Presti-Torres, J., Garcia, V.A., Scalco, F.S., Roesler, R. and Schröder, N. (2007): Adrenergic enhancement of consolidation of object recognition memory. Neurobiol. Learn. Mem., 88, 137-142.
11. Ennaceur, A. and Delacour, J. (1988): A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data. Behav. Brain Res., 31, 47-59.
12. Fanelli, R.F., Cangiano, C., Capocaccia, L., Cascino, A., Ceci, F., Muscaritoli, M. and Giunchi, G. (1986): Use of branched chain amino acids for treating hepatic encephalopathy: clinical experiences. Gut, 27 Suppl. 1, 111-115.
13. Ferenci, P., Lockwood, A., Mullen, K., Tarter, R., Weissenborn, K. and Blei, A.T. (2002): Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology, 35, 716-721.
14. Fontana, L., Moreira, E., Isabel Torres, M., Isabel Fernandez, M., Rios, A., De Medina, F.S. and Gil, A. (1996): Serum amino acid changes in rats with thioacetamide-induced liver cirrhosis. Toxicology, 106, 197-206.
15. Jover, R., Rodrigo, R., Felipo, V., Insausti, R., Saez-Valero, J., Garcia-Ayllon, M.S., Suarez, I., Candela, A., Compan, A., Esteban, A., Cauli, O., Auso, E., Rodriguez, E., Gutierrez, A., Girona, E., Erceg, S., Berbel, P. and Perez-Mateo, M. (2006): Brain edema and inflammatory activation in bile duct ligated rats with diet-induced hyperammonemia: A model of hepatic encephalopathy in cirrhosis. Hepatology, 43, 1257-1266.
16. Kawai, H., Kudo, N., Kawashima, Y. and Mitsumoto, A. (2009): Efficacy of urine bile acid as a non-invasive indicator of liver damage in rats. J. Toxicol. Sci., 34, 27-38.
17. King, M.V., Sleight, A.J., Woolley, M.L., Topham, I.A., Marsden, C.A. and Fone, K.C.F. (2004): 5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation--an effect sensitive to NMDA receptor antagonism. Neuropharmacology, 47, 195-204.
18. Lozeva-Thomas, V. (2004): Serotonin Brain Circuits with a Focus on Hepatic Encephalopathy. Metab. Brain Dis., 19, 413-420.
19. Matkowskyj, K.A., Marrero, J.A., Carroll, R.E., Danilkovich, A.V., Green, R.M. and Benya, R.V. (1999): Azoxymethane-induced fulminant hepatic failure in C57BL/6J mice: characterization of a new animal model. Am. J. Physiol., 277, G455-62.
20. Méndez, M., Méndez-López, M., López, L., Aller, M. Á., Árias, J., Cimadevilla, J.M. and Árias, J.L. (2008a): Spatial memory alterations in three models of hepatic encephalopathy. Behav. Brain Res., 188, 32-40.
21. Méndez, M., Méndez-López, M., López, L., Aller, M. Á., Árias, J. and Árias, J.L. (2008b): Working memory impairment and reduced hippocampal and prefrontal cortex c-Fos expression in a rat model of cirrhosis. Physiol. Behav., 95, 302-307.
22. Méndez, M., Méndez-López, M., López, L., Aller, M. Á., Árias, J. and Árias, J.L. (2009): Basal and learning task-related brain oxidative metabolism in cirrhotic rats. Brain Res. Bull., 78, 195-201.
23. Méndez, M., Méndez-López, M., López, L., Aller, M. Á., Árias, J. and Árias, J.L. (2011): Acetylcholinesterase activity in an experimental rat model of Type C hepatic encephalopathy. Acta Histochem., 113, 358-362.
24. Mortensen, P.B. (1992): The effect of oral-administered lactulose on colonic nitrogen metabolism and excretion. Hepatology, 16, 1350-1356.
25. rd, Dileone, R.J., Birnbaum, S.G., Cooper, D.C. and McClung, C.A. (2010): Knockdown of Clock in the Ventral Tegmental Area Through RNA Interference Results in a Mixed State of Mania and Depression-Like Behavior. Biol. Psych., 68, 503-511.
26. Müller, A., Machnik, F., Zimmermann, T. and Schubert, H. (1988): Thioacetamide-induced cirrhosis-like liver lesions in rats--usefulness and reliability of this animal model. Exp. Pathol., 34, 229-236.
27. Nirogi, R., Abraham, R., Jayarajan, P., Medapati, R.B., Shanmuganathan, D., Kandikere, V., Irappanavar, S., Saralaya, R., Benade, V., Bhyrapuneni, G. and Muddana, N. (2012): Difference in the norepinephrine levels of experimental and nonexperimental rats with age in the object recognition task. Brain Res., 1453, 40-45.
28. Noda, Y., Yamada, K., Furukawa, H. and Nabeshima, T. (1995): Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia. Br. J. Pharmacol., 116, 2531-2537.
29. Noda, Y., Mamiya, T., Furukawa, H. and Nabeshima, T. (1997): Effects of antidepressants on phencyclidine-induced enhancement of immobility in a forced swimming test in mice. Eur. J. Pharmacol., 324, 135-140.
30. Pitsikas, N. and Sakellaridis, N. (2005): The 5-HT2C receptor antagonist RO 60-0491 counteracts rats' retention deficits in a recognition memory task. Brain Res., 1054, 200-202.
31. Porsolt, R.D., Anton, G., Blavet, N. and Jalfre, M. (1978): Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol., 47, 379-391.
32. Prasad, S., Dhiman, R.K., Duseja, A., Chawla, Y.K., Sharma, A. and Agarwal, R. (2007): Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology, 45, 549-559.
33. Rahman, T.M., Selden, A.C. and Hodgson H.J.F. (2002): A novel model of acetaminophen-induced acute hepatic failure in rabbits. J. Surg. Res., 106, 264-272.
34. Roybal, K., Theobold, D., Graham, A., DiNieri, J.A., Russo, S.J., Krishnan, V., Chakravarty, S., Peevey, J., Oehrlein, N., Birnbaum, S., Vitaterna, M.H., Orsulak, P., Takahashi, J.S., Nestler, E.J., Carlezon, W.A., Jr. and McClung, C.A. (2007). Mania-like behavior induced by disruption of CLOCK. Proc. Natl. Acad. Sci. USA, 104, 6406-6411.
35. Sato, M., Kakubari, M., Kawamura, M., Sugimoto, J., Matsumoto, K. and Ishii, T. (2000): The decrease in total collagen fibers in the liver by hepatocyte growth factor after formation of cirrhosis induced by thioacetamide. Biochem. Pharmacol., 59, 681-690.
36. Schiapparelli, L., Simon, A.M., Del Rio, J. and Frechilla, D. (2006): Opposing effects of AMPA and 5-HT1A receptor blockade on passive avoidance and object recognition performance: correlation with AMPA receptor subunit expression in rat hippocampus. Neuropharmacology, 50, 897-907.
37. Scotti, M.A., Lee, G., Stevenson, S.A., Ostromecki, A.M., Wied, T.J., Kula, D.J., Gessay, G.M. and Gammie, S.C. (2011): Behavioral and pharmacological assessment of a potential new mouse model for mania. Physiol. Behav., 103, 376-383.
38. Steindl, P.E., Coy, D.L., Finn, B., Zee, P.C. and Blei, A.T. (1996): A low-protein diet ameliorates disrupted diurnal locomotor activity in rats after portacaval anastomosis. Am. J. Physiol., 271, G555-560.
39. Watanabe, M., Ozaki, T., Mushiroi, T., Ukai, Y., Ueda, F., Kimura, K., Katoh, M., Matsumoto, A., Kotani, E., Itoh, S., Yamaguchi, K. and Kyuki, K. (1997): Behavioral and electroencephalographic studies of beagles with an Eck's fistula: suitability as a model of hepatic encephalopathy. Pharmacol. Biochem. Behav., 57, 367-375.
40. Yamamoto, H. and Sugihara, N. (1987): Blood ammonia levels and hepatic encephalopathy induced by CCl4 in rats. Toxicol. Appl. Pharmacol., 91, 461-468.
41. Yurdaydin, C., Herneth, A.M., Puspok, A., Steindl, P., Singer, E. and Ferenci, P. (1996). Modulation of hepatic encephalopathy in rats with thioacetamide-induced acute liver failure by serotonin antagonists. Eur. J. Gastroenterol. Hepatol., 8, 667-671.
42. Zimmermann, C., Ferenci, P., Pifl, C., Yurdaydin, C., Ebner, J., Lassmann, H., Roth, E. and Hortnagl, H. (1989). Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission. Hepatology, 9, 594-601.